Stop by booth #18154 to learn how Arima Genomics is redefining cancer diagnostics using whole-genome sequence and structure information. Arima’s assays are enabling a new era of comprehensive, clinically actionable therapy selection insight.

Stop by booth #1285 to learn how the Aventa Lymphoma test can help resolve ambiguous lymphoma diagnoses by evaluating all clinically relevant rearrangements in B- and T-cell lymphomas.

Join our corporate workshop and stop by booth #420. Learn how the Aventa Lymphoma test can help resolve ambiguous lymphoma diagnoses by evaluating all clinically relevant rearrangements in B- and T-cell lymphomas.

Stop by booth #120 to learn how the Aventa Lymphoma test can help resolve ambiguous lymphoma diagnoses by evaluating all clinically relevant rearrangements in B- and T-cell lymphomas.

Stop by Booth #12 to learn how the Aventa FusionPlus and Aventa Lymphoma tests can help detect actionable fusions and rearrangements in FFPE tumor samples that are missed by other clinical testing modalities.

Follow the link to book a meeting with a member of our team.

Stop by Booth #32169 to learn how the Aventa FusionPlus and Aventa Lymphoma tests can help detect actionable fusions and rearrangements in FFPE tumor samples that are missed by other clinical testing modalities.

Follow the link to book a meeting with a member of our team.

Stop by the Arima booth #1034 to learn how the Aventa FusionPlus and Aventa Lymphoma tests can help detect actionable fusions and rearrangements in FFPE tumor samples that are missed by other clinical testing modalities.